Rutgers’ RUCDR Infinite Biologics and its collaborators has been granted emergency use authorization (EUA) by the Food and Drug Administration (FDA), for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. This new saliva collection method was developed by RUCDR in … Continue reading New COVID-19 Saliva Test Could be Game Changer, Limiting Exposure